XML 24 R13.htm IDEA: XBRL DOCUMENT v3.22.1
Earnings Per Share
3 Months Ended
Mar. 31, 2022
Earnings Per Share [Abstract]  
Earnings Per Share

4.

Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share for the three months ended March 31, 2022 and 2021 (in thousands, except per share amounts):

 

 

 

Three Months Ended

March 31,

 

 

 

2022

 

 

2021

 

Numerator:

 

 

 

 

 

 

 

 

Income from continuing operations attributable to

   Acadia Healthcare Company, Inc.

 

$

60,837

 

 

$

22,358

 

Loss from discontinued operations

 

 

 

 

 

(12,641

)

Net income attributable to Acadia Healthcare

    Company, Inc.

 

$

60,837

 

 

$

9,717

 

Denominator:

 

 

 

 

 

 

 

 

Weighted average shares outstanding for basic

   earnings per share

 

 

89,258

 

 

 

88,242

 

Effects of dilutive instruments

 

 

1,754

 

 

 

1,699

 

Shares used in computing diluted earnings per

   common share

 

 

91,012

 

 

 

89,941

 

 

 

 

 

 

 

 

 

 

Basic earnings per share attributable to Acadia

   Healthcare Company, Inc. stockholders:

 

 

 

 

 

 

 

 

Income from continuing operations attributable to

    Acadia Healthcare Company, Inc.

 

$

0.68

 

 

$

0.25

 

Loss from discontinued operations

 

 

 

 

 

(0.14

)

Net income attributable to Acadia Healthcare

    Company, Inc.

 

$

0.68

 

 

$

0.11

 

 

 

 

 

 

 

 

 

 

Diluted earnings per share attributable to Acadia

   Healthcare Company, Inc. stockholders:

 

 

 

 

 

 

 

 

Income from continuing operations attributable to

    Acadia Healthcare Company, Inc.

 

$

0.67

 

 

$

0.25

 

Loss from discontinued operations

 

 

 

 

 

(0.14

)

Net income attributable to Acadia Healthcare

    Company, Inc.

 

$

0.67

 

 

$

0.11

 

 

Approximately 0.7 million shares of common stock issuable upon exercise of outstanding stock option awards were excluded from the calculation of diluted earnings per share for both the three months ended March 31, 2022 and 2021, because their effect would have been anti-dilutive.